Squamous cell carcinoma: Difference between revisions
| Line 6: | Line 6: | ||
* UV radiation | * UV radiation | ||
* Chronic [[arsenic]] exposure | * Chronic [[arsenic]] exposure | ||
* Immunosuppression <ref>National Cancer Institute. Skin Cancer Treatment https://www.cancer.gov/types/skin/patient/skin-treatment-pdq</ref> | * Ionizing radiation | ||
* Immunosuppression | |||
* Chronic skin inflammation <ref>National Cancer Institute. Skin Cancer Treatment https://www.cancer.gov/types/skin/patient/skin-treatment-pdq</ref> | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Revision as of 17:00, 31 October 2019
Background
- Second most common skin cancer
- Higher rates of metastasis than basal cell carcinoma
Risk Factors
- UV radiation
- Chronic arsenic exposure
- Ionizing radiation
- Immunosuppression
- Chronic skin inflammation [1]
Differential Diagnosis
Evaluation
- Clinical examination by trained clinician (dermatology referral)
- Skin biopsy
Management
- Not typically managed within ED
Disposition
- Discharge with dermatology follow-up
See Also
External Links
References
- ↑ National Cancer Institute. Skin Cancer Treatment https://www.cancer.gov/types/skin/patient/skin-treatment-pdq